Medicine and Dentistry
Abdominal Cancer
16%
Cancer Therapy
16%
Carbon 13
16%
Cohort Effect
16%
Disease
50%
Eradication Therapy
16%
Geriatrics
33%
Helicobacter Infection
100%
Infection
16%
Metronidazole
33%
Multivariate Logistic Regression Analysis
16%
Nonsteroid Antiinflammatory Agent
16%
Patient Referral
50%
Predictive Factor
16%
Prevalence
16%
Proton-Pump Inhibitor
16%
Pylorus
50%
Recurrent Disease
16%
Urea Breath Test
100%
Urea C 13
100%
Keyphrases
Chronic Use
16%
Cohort Effect
16%
Demographic Data
16%
Eradication Therapy
16%
Gastric Cancer Surgery
16%
Geriatric Patients
16%
Geriatric Population
16%
Helicobacter Pylori (H. pylori)
33%
Helicobacter Pylori Infection
100%
High Prevalence
16%
Inflammatory Subtype
16%
Israeli
33%
Logistic Regression Analysis
16%
Metronidazole
16%
Metronidazole Resistance
16%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
16%
Peptic Disease
50%
Predictive Factors
16%
Proton Pump Inhibitors
16%
Referral Patterns
16%
Symptom Recurrence
16%
Treatment Combination
16%
Treatment Results
16%
Urea
16%
Urea Breath Test
100%
Well-defined
16%
Pharmacology, Toxicology and Pharmaceutical Science
Abdominal Cancer
16%
Carbon 13
16%
Disease
50%
Epidemiology
16%
Helicobacter Infection
100%
Infection
16%
Metronidazole
33%
Non-Steroidal Anti-Inflammatory Drug
16%
Prevalence
16%
Proton Pump Inhibitor
16%
Recurrent Disease
16%
Urea Breath Test
100%
Urea C 13
100%